2014•Heart failureRequires access

Inotropes and vasopressors

Roy S. Gardner, Theresa A. McDonagh, Niki L. Walker

Open publisher page 1 citations

Abstract

Abstract Inotropes are often used to offer haemodynamic support to patients with decompensated heart failure and cardiogenic shock. Although several drugs with inotropic activity are available, it has become increasingly evident that these drugs are associated with important negative effects. The positive inotropic actions of many of these agents are based on increased intracellular calcium concentrations, which may enhance myocardial energy consumption and arrhythmias. This chapter describes the pharmacology and evidence base for the use of inotropes in patients with heart failure.

About this research paper

What this paper is about

Abstract Inotropes are often used to offer haemodynamic support to patients with decompensated heart failure and cardiogenic shock. Although several drugs with inotropic activity are available, it has become increasingly evident that these drugs are associated with important negative effects. The positive inotropic actions of many of these agents are based on increased intracellular calcium concentrations, which may enhance myocardial energy consumption and arrhythmias. This chapter describes the pharmacology and evidence base for the use of inotropes in patients with heart failure.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Abstract Inotropes are often used to offer haemodynamic support to patients with decompensated heart failure and cardiogenic shock. Although several drugs with inotropic activity are available, it has become increasingly evident that these drugs are associated with important negative effects. The positive inotropic actions of many of these agents are based on increased intracellular calcium concentrations, which may enhance myocardial energy consumption and arrhythmias. This chapter describes the pharmacology and evidence base for the use of inotropes in patients with heart failure.

Key concepts: Inotrope, Cardiogenic shock, Heart failure, Shock (circulatory), Medicine, Cardiology, Levosimendan, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Inotropes and vasopressors — Research Paper | ScholarLens